News
Stockhead on MSN11m
FDA feedback gives Argenica clear path to lift clinical hold on brain drug
Argenica Therapeutics now has a clear path forward to clear the clinical hold currently in place on its investigational new .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback